Spectrum Disease Neuromyelitis Optica: Clinical Trials

1 trial for Spectrum Disease Neuromyelitis Optica, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 not yet recruiting. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Not yet recruiting 1

Follow Spectrum Disease Neuromyelitis Optica: new trials by email Literature Review of Spectrum Disease Neuromyelitis Optica trials Research Report on Spectrum Disease Neuromyelitis Optica

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Comparative Study of Two Vaccination Schedules for the Subunit Herpes Zoster Vaccine in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disease Patients Treated With Anti-CD20 Therapy: an Open-label Randomised Controlled Trial
Two-dose M0-M2 vaccination schedule, Two-dose M0-M6 vaccination schedule - Vaccine, Varicella-zoster Virus
Phase 4Not yet recruitingUniversity Hospital, Toulouse1602026-10-202026-09-14

Narrower conditions

Chickenpox (1)  ·  Herpes Zoster (1)  ·  Multiple Sclerosis (1)

Broader conditions

Autoimmune Diseases (1)  ·  Autoimmune Diseases of the Nervous System (1)  ·  DNA Virus Infections (1)  ·  Demyelinating Autoimmune Diseases, CNS (1)  ·  Demyelinating Diseases (1)  ·  Herpesviridae Infections (1)  ·  Immune System Diseases (1)  ·  Infections (1)  ·  Nervous System Diseases (1)  ·  Varicella Zoster Virus Infection (1)  ·  Virus Diseases (1)

Sponsors

University Hospital, Toulouse (1)

Countries

France (1)

Top investigators

Jonathan Ciron, MD (1)

NIH funding

2025 (1)